Genocea Biosciences (NASDAQ:GNCA) Earns Sell Rating from Analysts at StockNews.com
StockNews.com started coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Free Report) in a research note published on Thursday. The firm issued a sell rating on the biotechnology company’s stock. Genocea Biosciences Price Performance The company has a market capitalization of $6,000.00, a P/E ratio of 0.00 and a beta of 1.61. The company has […]
More Stories
News from the WHO: Types of data requested to inform December 2024 COVID-19 vaccine antigen composition deliberations https://ift.tt/NUaBW5H October 07, 2024 at 07:00AM
Published on October 07, 2024 at 07:00AM View on website
‘It’s Our Hurricane Katrina’: Asheville Residents Describe Death, Destruction, Danger After Hurricane Helene
By Arjun Singh ASHEVILLE. N.C.—Tunnel Road is a major thoroughfare between Asheville and the Swannanoa Valley in western North Carolina....
California Faces Wave of Lawsuits Over Gender Identity Notification in Schools
By Brad Jones A mother’s tears of worry and frustration over her 17-year-old daughter’s secret social gender transition at school...
Brokerages Set Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Price Target at $60.56
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) has received a consensus rating of “Moderate Buy” from the twenty ratings...
Lennar Co. (LEN) to Issue Quarterly Dividend of $0.50 on October 24th
Lennar Co. (NYSE:LEN – Get Free Report) announced a quarterly dividend on Wednesday, September 25th, NASDAQ reports. Shareholders of record...
Industria de Diseño Textil, S.A. (OTCMKTS:IDEXY) Plans Dividend of $0.29
Industria de Diseño Textil, S.A. (OTCMKTS:IDEXY – Get Free Report) announced a dividend on Saturday, October 5th, NASDAQ reports. Investors...